Healthy volunteers test new drug combinations in Early-Stage trial
NCT ID NCT07267221
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-phase study is testing three experimental drugs (DWJ1622, DWC202313, and DWC202314) in 36 healthy adults. The goal is to see how the body absorbs and processes these drugs and to check for any safety issues. Participants will take the drugs by mouth after eating. This trial is not intended to treat any disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- DWJ1622, DWC202313, DWC202314
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
H Plus YANGJI Hospital
RECRUITINGSeoul, Gwanak-gu, 08779, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug pass its first safety hurdle?
- Can a new drug play nice with common medicines? a trial investigates
- Could a new pill quiet chronic pain? early trial puts it to the test
- Brain waves under pressure: can light uncover the signature of mental work?
- Can acting as patients teach nurses to truly listen?
- Who decides for you? survey asks incarcerated older adults